🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Study comparing 2 formulations of bosutinib in healthy subjects....
Status
Completed
Location
Pfizer Investigational Site
Start Date
2010-02
Trial ID
NCT01080365
Treatments Being Tested
The purpose of this study is to see if there is an effect on the pharmacoki...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2009-08
Trial ID
NCT00952913
Treatments Being Tested
The combination of bosutinib plus atezolizumab in first line treatment in n...
Status
Terminated
Location
Hospital Universitario Ramón y Cajal
Start Date
2021-02-24
Trial ID
NCT04793399
Treatments Being Tested
This study evaluates the effect of Bosutinib (Bosulif,Pfizer®) in the treat...
Status
Completed
Location
MedStar Georgetown University Hospital
Start Date
2019-04-23
Trial ID
NCT03888222
Treatments Being Tested
Two-arm, randomized, open-label trial designed to evaluate the efficacy and...
Status
Completed
Location
Pacific Cancer Medical Center Inc
Start Date
2008-02-05
Trial ID
NCT00574873
This study will address the therapeutic activity and the safety/biological ...
Status
Unknown
Location
Presidio Ospedaliero "Oncologico Businco" - Cagliari (CA)
Start Date
2021-02-01
Trial ID
NCT04709731
Treatments Being Tested
The study is designed to compare the efficacy of asciminib 80 mg QD versus ...
Status
Active Not Recruiting
Location
Rocky Mountain Cancer Centers
Start Date
2021-10-06
Trial ID
NCT04971226
The purpose of this pivotal study was to compare the efficacy of asciminib ...
Status
Completed
Location
University of Chicago Hospital
Start Date
2017-10-26
Trial ID
NCT03106779
This is a two-part safety and efficacy study of SKI-606 in subjects who hav...
Status
Completed
Location
Kumamoto University Hospital
Start Date
2007-12
Trial ID
NCT00811070
Treatments Being Tested